These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 23674405)
1. Variability in neuronal expression of dopamine receptors and transporters in the substantia nigra. Reyes S; Cottam V; Kirik D; Double KL; Halliday GM Mov Disord; 2013 Sep; 28(10):1351-9. PubMed ID: 23674405 [TBL] [Abstract][Full Text] [Related]
2. On the properties of identified dopaminergic neurons in the mouse substantia nigra and ventral tegmental area. Krashia P; Martini A; Nobili A; Aversa D; D'Amelio M; Berretta N; Guatteo E; Mercuri NB Eur J Neurosci; 2017 Jan; 45(1):92-105. PubMed ID: 27519559 [TBL] [Abstract][Full Text] [Related]
3. Inverse relationship between the contents of neuromelanin pigment and the vesicular monoamine transporter-2: human midbrain dopamine neurons. Liang CL; Nelson O; Yazdani U; Pasbakhsh P; German DC J Comp Neurol; 2004 May; 473(1):97-106. PubMed ID: 15067721 [TBL] [Abstract][Full Text] [Related]
4. Subcellular distribution and plasticity of neurokinin-1 receptors in the rat substantia nigra and ventral tegmental area. Lessard A; Pickel VM Neuroscience; 2005; 135(4):1309-23. PubMed ID: 16165296 [TBL] [Abstract][Full Text] [Related]
5. A cytoarchitectonic and chemoarchitectonic analysis of the dopamine cell groups in the substantia nigra, ventral tegmental area, and retrorubral field in the mouse. Fu Y; Yuan Y; Halliday G; Rusznák Z; Watson C; Paxinos G Brain Struct Funct; 2012 Apr; 217(2):591-612. PubMed ID: 21935672 [TBL] [Abstract][Full Text] [Related]
6. Neurochemical characterization of the release and uptake of dopamine in ventral tegmental area and serotonin in substantia nigra of the mouse. John CE; Budygin EA; Mateo Y; Jones SR J Neurochem; 2006 Jan; 96(1):267-82. PubMed ID: 16300629 [TBL] [Abstract][Full Text] [Related]
7. Signalling through phospholipase C beta 4 is not essential for midbrain dopaminergic neuron survival. Smits SM; van der Nobelen S; Hornman KJ; von Oerthel L; Burbach JP; Smidt MP Neuroscience; 2005; 136(1):171-9. PubMed ID: 16198487 [TBL] [Abstract][Full Text] [Related]
8. Damage to dopamine systems differs between Parkinson's disease and Alzheimer's disease with parkinsonism. Murray AM; Weihmueller FB; Marshall JF; Hurtig HI; Gottleib GL; Joyce JN Ann Neurol; 1995 Mar; 37(3):300-12. PubMed ID: 7695230 [TBL] [Abstract][Full Text] [Related]
9. Some dopamine neurons may be more impulsive than others: why differences in receptors and transporters can affect dopamine function in Parkinson's disease. Chang CH; Grace AA Mov Disord; 2013 Sep; 28(10):1319-20. PubMed ID: 23847128 [No Abstract] [Full Text] [Related]
10. GIRK2 expression in dopamine neurons of the substantia nigra and ventral tegmental area. Reyes S; Fu Y; Double K; Thompson L; Kirik D; Paxinos G; Halliday GM J Comp Neurol; 2012 Aug; 520(12):2591-607. PubMed ID: 22252428 [TBL] [Abstract][Full Text] [Related]
11. Differential modification of dopamine transporter and tyrosine hydroxylase mRNAs in midbrain of subjects with Parkinson's, Alzheimer's with parkinsonism, and Alzheimer's disease. Joyce JN; Smutzer G; Whitty CJ; Myers A; Bannon MJ Mov Disord; 1997 Nov; 12(6):885-97. PubMed ID: 9399211 [TBL] [Abstract][Full Text] [Related]
12. Activation of ventral tegmental area dopamine neurons produces wakefulness through dopamine D Oishi Y; Suzuki Y; Takahashi K; Yonezawa T; Kanda T; Takata Y; Cherasse Y; Lazarus M Brain Struct Funct; 2017 Aug; 222(6):2907-2915. PubMed ID: 28124114 [TBL] [Abstract][Full Text] [Related]
14. Dopamine transporter messenger RNA in Parkinson's disease and control substantia nigra neurons. Uhl GR; Walther D; Mash D; Faucheux B; Javoy-Agid F Ann Neurol; 1994 Apr; 35(4):494-8. PubMed ID: 8154880 [TBL] [Abstract][Full Text] [Related]
15. Glucocorticoid receptor expression and sub-cellular localization in dopamine neurons of the rat midbrain. Hensleigh E; Pritchard LM Neurosci Lett; 2013 Nov; 556():191-5. PubMed ID: 24121048 [TBL] [Abstract][Full Text] [Related]
16. Regional distribution of monoamine vesicular uptake sites in the mesencephalon of control subjects and patients with Parkinson's disease: a postmortem study using tritiated tetrabenazine. Thibaut F; Faucheux BA; Marquez J; Villares J; Menard JF; Agid Y; Hirsch EC Brain Res; 1995 Sep; 692(1-2):233-43. PubMed ID: 8548309 [TBL] [Abstract][Full Text] [Related]
17. Differential expression of the homeobox gene Pitx3 in midbrain dopaminergic neurons. Korotkova TM; Ponomarenko AA; Haas HL; Sergeeva OA Eur J Neurosci; 2005 Sep; 22(6):1287-93. PubMed ID: 16190884 [TBL] [Abstract][Full Text] [Related]